- Home
- BYD vs PTCT Comparison
BYD vs PTCT Comparison
Compare BYD & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYD | PTCT |
|---|---|---|
| Founded | 1973 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.1B |
| IPO Year | 1993 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BYD | PTCT |
|---|---|---|
| Price | $83.24 | $74.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 18 |
| Target Price | ★ $90.27 | $76.28 |
| AVG Volume (30 Days) | 830.3K | ★ 1.2M |
| Earning Date | 02-05-2026 | 02-19-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | ★ 264.46 | N/A |
| EPS | ★ 22.56 | 8.94 |
| Revenue | ★ $4,091,989,000.00 | $1,779,150,000.00 |
| Revenue This Year | $3.53 | $132.16 |
| Revenue Next Year | $0.02 | N/A |
| P/E Ratio | ★ $3.71 | $8.09 |
| Revenue Growth | 4.12 | ★ 97.54 |
| 52 Week Low | $58.94 | $35.95 |
| 52 Week High | $89.96 | $87.50 |
Technical Indicators
Market Signals| Indicator | BYD | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 40.53 | 43.78 |
| Support Level | $82.54 | $71.35 |
| Resistance Level | $86.77 | $76.99 |
| Average True Range (ATR) | 1.79 | 2.92 |
| MACD | -0.32 | -0.25 |
| Stochastic Oscillator | 13.47 | 45.22 |
Price Performance
Historical ComparisonAbout BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.